Dramatic lowering of very high Lp(a) in response to niacin

Abstract We describe a patient with markedly elevated lipoprotein(a) (Lp(a)) without any other lipid abnormalities. After a myocardial infarction, she was treated with combination of extended-release niacin and statin. An 88% reduction in Lp(a) was observed during 5 years of treatment, which is much...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical lipidology 2014-07, Vol.8 (4), p.448-450
Hauptverfasser: Li, Min, MD, PhD, Saeedi, Ramesh, MD, PhD, Rabkin, Simon W., MD, Frohlich, Jiri, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 450
container_issue 4
container_start_page 448
container_title Journal of clinical lipidology
container_volume 8
creator Li, Min, MD, PhD
Saeedi, Ramesh, MD, PhD
Rabkin, Simon W., MD
Frohlich, Jiri, MD
description Abstract We describe a patient with markedly elevated lipoprotein(a) (Lp(a)) without any other lipid abnormalities. After a myocardial infarction, she was treated with combination of extended-release niacin and statin. An 88% reduction in Lp(a) was observed during 5 years of treatment, which is much better response than usually reported.
doi_str_mv 10.1016/j.jacl.2014.03.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1552807515</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1933287414002098</els_id><sourcerecordid>1552807515</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-6e8c9ce83407389e3e27e4289ae7a5c0012e79c48966e991b6747063de9769a03</originalsourceid><addsrcrecordid>eNp9kctuFDEQRS1ERJ4_kEXkZVh0U7bbL4QioYRHpJFYkKwtx1OTuOmxB7snaP6ebk1gwYJV1eLcK9UpQs4ZtAyYete3vQ9Dy4F1LYgWQL0iR8xo1XTa2NfTboVouNHdITmutQeQUoN8Qw65ZAw410fk_U3xaz_GQIf8C0tMjzSv6DOWHX2Kj090sbn0b2lMtGDd5FSRjpmm6ENMp-Rg5YeKZy_zhNx__nR3_bVZfPtye_1x0YTOsLFRaIINaEQHWhiLArnGjhvrUXsZABhHbSfWKoXWsgelOw1KLNFqZT2IE3K5792U_HOLdXTrWAMOg0-Yt9UxKbkBLZmcUL5HQ8m1Fly5TYlrX3aOgZudud7NztzszIFwk7MpdPHSv31Y4_Jv5I-kCfiwB3C68jlicTVETAGXsWAY3TLH__df_RMPQ0wx-OEH7rD2eVvS5M8xV7kD933-2vw01gFwsEb8Bm4pjxU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1552807515</pqid></control><display><type>article</type><title>Dramatic lowering of very high Lp(a) in response to niacin</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Li, Min, MD, PhD ; Saeedi, Ramesh, MD, PhD ; Rabkin, Simon W., MD ; Frohlich, Jiri, MD</creator><creatorcontrib>Li, Min, MD, PhD ; Saeedi, Ramesh, MD, PhD ; Rabkin, Simon W., MD ; Frohlich, Jiri, MD</creatorcontrib><description>Abstract We describe a patient with markedly elevated lipoprotein(a) (Lp(a)) without any other lipid abnormalities. After a myocardial infarction, she was treated with combination of extended-release niacin and statin. An 88% reduction in Lp(a) was observed during 5 years of treatment, which is much better response than usually reported.</description><identifier>ISSN: 1933-2874</identifier><identifier>EISSN: 1876-4789</identifier><identifier>DOI: 10.1016/j.jacl.2014.03.006</identifier><identifier>PMID: 25110227</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Atorvastatin Calcium ; Biomarkers - metabolism ; Cardiovascular ; Coronary artery disease (CAD) ; Coronary Artery Disease - complications ; Coronary Artery Disease - diagnosis ; Coronary Artery Disease - drug therapy ; Disease-Free Survival ; Female ; Heptanoic Acids - therapeutic use ; Humans ; Hypolipidemic Agents - therapeutic use ; Lipoprotein(a) - metabolism ; Lipoprotein(a) [Lp(a)] ; Middle Aged ; Myocardial Infarction - diagnosis ; Myocardial Infarction - drug therapy ; Myocardial Infarction - etiology ; Niacin ; Niacin - therapeutic use ; Pyrroles - therapeutic use ; Risk ; Statin</subject><ispartof>Journal of clinical lipidology, 2014-07, Vol.8 (4), p.448-450</ispartof><rights>National Lipid Association</rights><rights>2014 National Lipid Association</rights><rights>Copyright © 2014 National Lipid Association. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-6e8c9ce83407389e3e27e4289ae7a5c0012e79c48966e991b6747063de9769a03</citedby><cites>FETCH-LOGICAL-c481t-6e8c9ce83407389e3e27e4289ae7a5c0012e79c48966e991b6747063de9769a03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jacl.2014.03.006$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25110227$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Min, MD, PhD</creatorcontrib><creatorcontrib>Saeedi, Ramesh, MD, PhD</creatorcontrib><creatorcontrib>Rabkin, Simon W., MD</creatorcontrib><creatorcontrib>Frohlich, Jiri, MD</creatorcontrib><title>Dramatic lowering of very high Lp(a) in response to niacin</title><title>Journal of clinical lipidology</title><addtitle>J Clin Lipidol</addtitle><description>Abstract We describe a patient with markedly elevated lipoprotein(a) (Lp(a)) without any other lipid abnormalities. After a myocardial infarction, she was treated with combination of extended-release niacin and statin. An 88% reduction in Lp(a) was observed during 5 years of treatment, which is much better response than usually reported.</description><subject>Atorvastatin Calcium</subject><subject>Biomarkers - metabolism</subject><subject>Cardiovascular</subject><subject>Coronary artery disease (CAD)</subject><subject>Coronary Artery Disease - complications</subject><subject>Coronary Artery Disease - diagnosis</subject><subject>Coronary Artery Disease - drug therapy</subject><subject>Disease-Free Survival</subject><subject>Female</subject><subject>Heptanoic Acids - therapeutic use</subject><subject>Humans</subject><subject>Hypolipidemic Agents - therapeutic use</subject><subject>Lipoprotein(a) - metabolism</subject><subject>Lipoprotein(a) [Lp(a)]</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - diagnosis</subject><subject>Myocardial Infarction - drug therapy</subject><subject>Myocardial Infarction - etiology</subject><subject>Niacin</subject><subject>Niacin - therapeutic use</subject><subject>Pyrroles - therapeutic use</subject><subject>Risk</subject><subject>Statin</subject><issn>1933-2874</issn><issn>1876-4789</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kctuFDEQRS1ERJ4_kEXkZVh0U7bbL4QioYRHpJFYkKwtx1OTuOmxB7snaP6ebk1gwYJV1eLcK9UpQs4ZtAyYete3vQ9Dy4F1LYgWQL0iR8xo1XTa2NfTboVouNHdITmutQeQUoN8Qw65ZAw410fk_U3xaz_GQIf8C0tMjzSv6DOWHX2Kj090sbn0b2lMtGDd5FSRjpmm6ENMp-Rg5YeKZy_zhNx__nR3_bVZfPtye_1x0YTOsLFRaIINaEQHWhiLArnGjhvrUXsZABhHbSfWKoXWsgelOw1KLNFqZT2IE3K5792U_HOLdXTrWAMOg0-Yt9UxKbkBLZmcUL5HQ8m1Fly5TYlrX3aOgZudud7NztzszIFwk7MpdPHSv31Y4_Jv5I-kCfiwB3C68jlicTVETAGXsWAY3TLH__df_RMPQ0wx-OEH7rD2eVvS5M8xV7kD933-2vw01gFwsEb8Bm4pjxU</recordid><startdate>201407</startdate><enddate>201407</enddate><creator>Li, Min, MD, PhD</creator><creator>Saeedi, Ramesh, MD, PhD</creator><creator>Rabkin, Simon W., MD</creator><creator>Frohlich, Jiri, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201407</creationdate><title>Dramatic lowering of very high Lp(a) in response to niacin</title><author>Li, Min, MD, PhD ; Saeedi, Ramesh, MD, PhD ; Rabkin, Simon W., MD ; Frohlich, Jiri, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-6e8c9ce83407389e3e27e4289ae7a5c0012e79c48966e991b6747063de9769a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Atorvastatin Calcium</topic><topic>Biomarkers - metabolism</topic><topic>Cardiovascular</topic><topic>Coronary artery disease (CAD)</topic><topic>Coronary Artery Disease - complications</topic><topic>Coronary Artery Disease - diagnosis</topic><topic>Coronary Artery Disease - drug therapy</topic><topic>Disease-Free Survival</topic><topic>Female</topic><topic>Heptanoic Acids - therapeutic use</topic><topic>Humans</topic><topic>Hypolipidemic Agents - therapeutic use</topic><topic>Lipoprotein(a) - metabolism</topic><topic>Lipoprotein(a) [Lp(a)]</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - diagnosis</topic><topic>Myocardial Infarction - drug therapy</topic><topic>Myocardial Infarction - etiology</topic><topic>Niacin</topic><topic>Niacin - therapeutic use</topic><topic>Pyrroles - therapeutic use</topic><topic>Risk</topic><topic>Statin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Min, MD, PhD</creatorcontrib><creatorcontrib>Saeedi, Ramesh, MD, PhD</creatorcontrib><creatorcontrib>Rabkin, Simon W., MD</creatorcontrib><creatorcontrib>Frohlich, Jiri, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical lipidology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Min, MD, PhD</au><au>Saeedi, Ramesh, MD, PhD</au><au>Rabkin, Simon W., MD</au><au>Frohlich, Jiri, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dramatic lowering of very high Lp(a) in response to niacin</atitle><jtitle>Journal of clinical lipidology</jtitle><addtitle>J Clin Lipidol</addtitle><date>2014-07</date><risdate>2014</risdate><volume>8</volume><issue>4</issue><spage>448</spage><epage>450</epage><pages>448-450</pages><issn>1933-2874</issn><eissn>1876-4789</eissn><abstract>Abstract We describe a patient with markedly elevated lipoprotein(a) (Lp(a)) without any other lipid abnormalities. After a myocardial infarction, she was treated with combination of extended-release niacin and statin. An 88% reduction in Lp(a) was observed during 5 years of treatment, which is much better response than usually reported.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>25110227</pmid><doi>10.1016/j.jacl.2014.03.006</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1933-2874
ispartof Journal of clinical lipidology, 2014-07, Vol.8 (4), p.448-450
issn 1933-2874
1876-4789
language eng
recordid cdi_proquest_miscellaneous_1552807515
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Atorvastatin Calcium
Biomarkers - metabolism
Cardiovascular
Coronary artery disease (CAD)
Coronary Artery Disease - complications
Coronary Artery Disease - diagnosis
Coronary Artery Disease - drug therapy
Disease-Free Survival
Female
Heptanoic Acids - therapeutic use
Humans
Hypolipidemic Agents - therapeutic use
Lipoprotein(a) - metabolism
Lipoprotein(a) [Lp(a)]
Middle Aged
Myocardial Infarction - diagnosis
Myocardial Infarction - drug therapy
Myocardial Infarction - etiology
Niacin
Niacin - therapeutic use
Pyrroles - therapeutic use
Risk
Statin
title Dramatic lowering of very high Lp(a) in response to niacin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T06%3A08%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dramatic%20lowering%20of%20very%20high%20Lp(a)%20in%20response%20to%20niacin&rft.jtitle=Journal%20of%20clinical%20lipidology&rft.au=Li,%20Min,%20MD,%20PhD&rft.date=2014-07&rft.volume=8&rft.issue=4&rft.spage=448&rft.epage=450&rft.pages=448-450&rft.issn=1933-2874&rft.eissn=1876-4789&rft_id=info:doi/10.1016/j.jacl.2014.03.006&rft_dat=%3Cproquest_cross%3E1552807515%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1552807515&rft_id=info:pmid/25110227&rft_els_id=S1933287414002098&rfr_iscdi=true